Statistics for Ys Biopharma Co Ltd. (id:5844 YS)
Valuation metrics
Market cap
192.09M
Enterprise value
59.23M
Trailing P/E (ttm)
-0.98
Forward P/E
-4.08
PEG ratio
-4.08
Price/Sales (ttm)
0.35
Price/Book (mrq)
0.20
Enterprise Value/Revenue
0.79
Enterprise Value/EBITDA
-1.44
Overview
Shares outstanding
188.33M
Float
17.10M
Shares short
38.89K
% Held by insiders
0.81%
% Held by institutions
0.03%
Average volume (10 days)
17.00K
Average volume (90 days)
Price summary
52-Week low
0.35
52-Week high
8.60
52-Week change
82.24%
Beta
0.54
50-Day moving average
0.87
200-Day moving average
0.66
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
March 31, 2023
Most recent quarter (mrq)
September 30, 2023
Profitability
Profit margin
-66.76%
Operating margin
-49.50%
Operational effectiveness
Return on assets
-10.14%
Return on equity
-77.80%
Income statement
Revenue (ttm)
4.67
Revenue per share (ttm)
4.67
Quarterly revenue growth (yoy)
Gross profit (ttm)
533.84M
EBITDA
-41,030,316.00
Net income to common (ttm)
-46,001,550.00
Diluted EPS (ttm)
-0.56
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
30.70M
Total cash per share (mrq)
2.39
Total debt (mrq)
76.97M
Total Debt/Equity (mrq)
117.61
Current ratio (mrq)
93.60%
Book value per share (mrq)
5.10
Cash flow
Cash flow statement
-244,497,473.00
Levered free cash flow (LFCF)
246.54M